Separating Biological and Choice Effects in Randomized Trials: Completing Causal Inference with β-Identification
This paper proposes a causal inference framework that decomposes randomized trial outcomes into biological effects () and preference-mediated choice effects (), arguing that formally identifying both components resolves ambiguity caused by nonadherence and crossover while providing a more complete understanding of treatment efficacy in preference-sensitive care.